Medicare Enrolled
Dr. Ronald Yglesias, M.D.
Rheumatology · Aventura, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yglesias from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yglesias?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yglesias
Dr. Ronald Yglesias is a rheumatology specialist in Aventura, FL, with 11 years of NPI registration. Based on federal Medicare data, Dr. Yglesias performed 106,802 Medicare services across 1,112 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yglesias received a total of $6,054 from 32 pharmaceutical and/or device companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yglesias is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 23% volume in FL
$6,054 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 132143 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗106,802
Medicare services
Top 23% in FL for rheumatology
1,112
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,709 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
41,400 | $4 | $10 |
| Romosozumab injection (Evenity) for osteoporosis | 34,651 | $8 | $11 |
| Tocilizumab injection (Actemra) | 18,407 | $5 | $7 |
| Denosumab injection (Prolia/Xgeva) | 8,220 | $18 | $27 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
1,440 | $27 | $70 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
469 | $60 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
455 | $103 | $167 |
| Physical therapy exercise, per 15 min A therapy session using exercises to improve strength, endurance, range of motion, and flexibility. Each 15-minute unit is billed separately. |
425 | $20 | $50 |
| Manual therapy (hands-on treatment), per 15 min | 185 | $18 | $70 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
114 | $9 | $25 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
104 | $106 | $250 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
103 | $4 | $15 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
95 | $0 | $1 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
83 | $24 | $60 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
62 | $58 | $133 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
58 | $131 | $254 |
| Neuromuscular re-education therapy, per 15 min A therapy procedure designed to re-educate the functional connection between the brain, nerves, and muscles. It is billed in 15-minute increments. |
55 | $26 | $47 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $76 | $109 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
49 | $0 | $7 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
48 | $103 | $275 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
48 | $41 | $100 |
| Self-care/home management training, per 15 min Instruction provided to help patients manage their own care or daily activities at home. The service is billed in 15-minute increments. |
47 | $20 | $44 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $39 | $69 |
| Refilling and maintenance of portable pump This service involves refilling and performing maintenance on a portable pump. |
39 | $108 | $300 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
39 | $0 | $30 |
| Hyaluronan intra-articular injection An injection of hyaluronan or a derivative into a joint to provide lubrication and cushioning. |
31 | $559 | $1,600 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
30 | $53 | $125 |
| Evaluation for physical therapy, typically 30 minutes | 23 | $84 | $137 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
23 | $1 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
97.1% medium
1.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,054
Total received (2018-2024)
Avg $865/year across 7 years
Bottom 48% in FL for rheumatology
32
Companies
294
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,054 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$841
2023
$1,767
2022
$1,234
2021
$1,121
2020
$462
2019
$341
2018
$288
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$695
AbbVie Inc.
$595
PFIZER INC.
$559
GlaxoSmithKline, LLC.
$503
ABBVIE INC.
$394
AstraZeneca Pharmaceuticals LP
$356
Aurinia Pharma U.S., Inc.
$317
Horizon Therapeutics plc
$304
Novartis Pharmaceuticals Corporation
$287
Lilly USA, LLC
$233
ANI Pharmaceuticals, Inc.
$225
E.R. Squibb & Sons, L.L.C.
$193
Janssen Biotech, Inc.
$165
Mallinckrodt Hospital Products Inc.
$156
Fresenius Kabi USA, LLC
$147
Radius Health, Inc.
$126
Alvogen Inc
$97
DePuy Synthes Sales Inc.
$90
Takeda Pharmaceuticals U.S.A., Inc.
$64
AbbVie, Inc.
$60
Organon LLC
$59
Mallinckrodt Enterprises LLC
$58
Octapharma USA, Inc.
$57
GENZYME CORPORATION
$54
Alexion Pharmaceuticals, Inc.
$48
Boston Scientific Corporation
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
Mallinckrodt LLC
$28
MEDEXUS PHARMA, INC.
$26
UCB, Inc.
$25
Pacira Therapeutics, Inc.
$22
Ultragenyx Pharmaceutical Inc.
$15
Top 3 companies account for 30.5% of total payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · BENLYSTA · BOTOX · COSENTYX · CRYSVITA · CUVITRU · CYLTEZO · Cimzia · DUEXIS · EVENITY · Enbrel · HADLIMA · HUMIRA · HYQVIA · Humira · ILARIS · INFLECTRA · KEVZARA · KRYSTEXXA · LUPKYNIS · MONOVISC · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · PANZYGA · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · TALTZ · TEPEZZA · TERIPARATIDE · TREMFYA · Tymlos · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $6 per 100 Medicare services performed
Geographic Context
Rheumatologists within 10 mi
93
Per 100K population
3.5
County median income
$68,694
Nearest hospital
HCA FLORIDA AVENTURA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Yglesias is a mixed practice specialist, with above-average Medicare volume (top 23% in FL), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Yglesias experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Yglesias performed 41,400 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yglesias receive payments from pharmaceutical companies?
Yes. Dr. Yglesias received a total of $6,054 from 32 companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yglesias's costs compare to other rheumatologists in Aventura?
Dr. Yglesias's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yglesias) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Aventura
Browse rheumatologists in Aventura ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology